AU2011256264B2 - Method for purifying a fused pyrrolocarbazole derivative - Google Patents
Method for purifying a fused pyrrolocarbazole derivative Download PDFInfo
- Publication number
- AU2011256264B2 AU2011256264B2 AU2011256264A AU2011256264A AU2011256264B2 AU 2011256264 B2 AU2011256264 B2 AU 2011256264B2 AU 2011256264 A AU2011256264 A AU 2011256264A AU 2011256264 A AU2011256264 A AU 2011256264A AU 2011256264 B2 AU2011256264 B2 AU 2011256264B2
- Authority
- AU
- Australia
- Prior art keywords
- formula
- compound
- theta
- degrees
- acid complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34583110P | 2010-05-18 | 2010-05-18 | |
| US61/345,831 | 2010-05-18 | ||
| PCT/US2011/036814 WO2011146488A1 (en) | 2010-05-18 | 2011-05-17 | Method for purifying a fused pyrrolocarbazole derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2011256264A1 AU2011256264A1 (en) | 2013-01-10 |
| AU2011256264B2 true AU2011256264B2 (en) | 2016-09-15 |
Family
ID=44168420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2011256264A Active AU2011256264B2 (en) | 2010-05-18 | 2011-05-17 | Method for purifying a fused pyrrolocarbazole derivative |
Country Status (20)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2399588T3 (es) | 2008-11-19 | 2013-04-02 | Cephalon, Inc. | Nuevas formas de un compuesto de indazolo[5,4-A]pirrolo[3,4-C]carbazol |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010059795A1 (en) * | 2008-11-19 | 2010-05-27 | Cephalon, Inc. | Novel forms of an indazolo [5,4-a] pyrrolo [3,4-c] carbazole compound |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60103171T2 (de) * | 2000-09-29 | 2004-11-11 | Eli Lilly And Co., Indianapolis | Verfahren und verbindungen zur behandlung proliferativer erkrankungen |
| US7169802B2 (en) | 2003-12-23 | 2007-01-30 | Cephalon, Inc. | Fused pyrrolocarbazoles |
| JP2006241579A (ja) | 2005-03-07 | 2006-09-14 | Nippon Paint Co Ltd | 化成処理剤及び表面処理金属 |
-
2011
- 2011-05-17 WO PCT/US2011/036814 patent/WO2011146488A1/en not_active Ceased
- 2011-05-17 EA EA201291269A patent/EA021869B1/ru not_active IP Right Cessation
- 2011-05-17 SG SG10201503541WA patent/SG10201503541WA/en unknown
- 2011-05-17 AU AU2011256264A patent/AU2011256264B2/en active Active
- 2011-05-17 NZ NZ604135A patent/NZ604135A/en unknown
- 2011-05-17 UA UAA201214484A patent/UA108498C2/ru unknown
- 2011-05-17 MY MYPI2012004977A patent/MY156830A/en unknown
- 2011-05-17 BR BR112012029374-5A patent/BR112012029374B1/pt active IP Right Grant
- 2011-05-17 CN CN201180024787.XA patent/CN102958934B/zh active Active
- 2011-05-17 CA CA2799517A patent/CA2799517C/en active Active
- 2011-05-17 KR KR1020127032917A patent/KR101815332B1/ko active Active
- 2011-05-17 JP JP2013511294A patent/JP5828594B2/ja active Active
- 2011-05-17 PH PH1/2012/502250A patent/PH12012502250A1/en unknown
- 2011-05-17 EP EP11721691.1A patent/EP2571885B1/en active Active
- 2011-05-17 MX MX2012013304A patent/MX2012013304A/es active IP Right Grant
- 2011-05-17 SG SG2012084851A patent/SG185645A1/en unknown
- 2011-05-17 ES ES11721691.1T patent/ES2530015T3/es active Active
-
2012
- 2012-11-13 IL IL223016A patent/IL223016A0/en active IP Right Grant
- 2012-11-16 US US13/678,886 patent/US8884014B2/en active Active
- 2012-11-16 CL CL2012003208A patent/CL2012003208A1/es unknown
- 2012-12-07 ZA ZA2012/09305A patent/ZA201209305B/en unknown
-
2015
- 2015-10-19 JP JP2015205469A patent/JP2016074668A/ja active Pending
- 2015-10-22 IL IL242221A patent/IL242221B/en active IP Right Grant
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010059795A1 (en) * | 2008-11-19 | 2010-05-27 | Cephalon, Inc. | Novel forms of an indazolo [5,4-a] pyrrolo [3,4-c] carbazole compound |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11168057B2 (en) | Polymorphs and co-crystals of roxadustat | |
| WO2009120746A2 (en) | Crystalline forms of sitagliptin phosphate | |
| CA2834821A1 (en) | Crystalline salts of asenapine | |
| HRP20030392A2 (en) | Crystalline venlafaxine base and novel polymorphsof venlafaxine hydrochloride, processes for preparing thereof | |
| EP3953339A1 (en) | Process for preparing 1-deoxy-1-methylamino-d-glucitol 2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate | |
| WO2011021218A2 (en) | Process for the preparation of 4-[3,5-bis(2-hydroxyphenyl)-1h-1,2,4-triazol-1-yl]-benzoic acid and its amine salts | |
| AU2011256264B2 (en) | Method for purifying a fused pyrrolocarbazole derivative | |
| EP3166942A1 (en) | Process for prepararing apixaban | |
| WO2014102834A2 (en) | Process for lurasidone | |
| HK1182100B (en) | Method for purifying a fused pyrrolocarbazole derivative | |
| JP2717995B2 (ja) | １，２，３−トリアゾールの製法 | |
| WO2016142173A1 (en) | 4-(2-methyl-1h-imidazol-1-yl)-2,2-diphenylbutanenitrile solid form | |
| JP7748370B2 (ja) | トリアゾリンジオン付加体の製造方法 | |
| BR112012029363B1 (pt) | Processo para preparar 1-alquil-3-difluorometil-5 -hidroxipirazóis | |
| US20100179318A1 (en) | Process to make lestaurtinib | |
| CN114790161A (zh) | 4-甲氧基羰基乙基-3-甲基-2-吡咯醛的合成方法及其中间体 | |
| US7589194B2 (en) | Crystalline k-252b, sodium salt, methanolate pentahydrate | |
| TW202540077A (zh) | 具有抗癌活性之ｍｄｍ２－ｐ５３交互作用的異吲哚啉酮抑制劑的中間體的製造方法 | |
| WO2011114336A1 (en) | Process for the isolation of ganciclovir intermediate | |
| WO2021009306A1 (en) | Improved process for preparing ozanimod | |
| US20080177063A1 (en) | CRYSTALLINE K-252b, SODIUM SALT, HYDRATE | |
| US20080171867A1 (en) | CRYSTALLINE K-252a BIS(TETRAHYDROFURANATE) | |
| WO2009014679A1 (en) | Dolasetron trifluoroacetate, polymorphs of dolasetron trifluoroacetate and process for preparation thereof | |
| WO2016021524A1 (ja) | 光学活性２－メチルピペラジンの製造方法 | |
| EP2462144A2 (en) | PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |